HealthTech

Latigo collects $150M to get non-opioid data to compete...

Latigo Biotherapeutics thinks it can one-up Vertex Pharmaceuticals' recently app...

Eli Lilly-backed Maxion Therapeutics raises $72M Series...

Maxion Therapeutics has secured $72 million in an oversubscribed Series A raise,...

How Are Telehealth CEOs Reacting to Congress’ Latest Sp...

Congress passed a continuing resolution last week that extended expiring Medicar...

Labcorp Is Buying BioReference Health’s Cancer Testing ...

Labcorp’s latest acquisition brings the oncology testing business of BioReferenc...

Cautious Pessimism – What Isn’t Being Talked About, And...

The lessons learned and shared by some of the industry’s leaders are exciting, a...

Bonus Features – March 16, 2025 – 69% of healthcare sta...

Welcome to the weekly edition of Healthcare IT Today Bonus Features. This articl...

The High Price of Treatment Resistant Depression for Em...

Workforce mental health isn’t just an HR issue, it’s also a business imperative....

Weekly Roundup – March 15, 2025

Welcome to our Healthcare IT Today Weekly Roundup. Each week, we’ll be providing...

Updates on health agency nominees; New data from Pfizer...

Welcome back to Endpoints Weekly. Our reporters tracked a flurry of deals and da...

Walgreens PE Buyout Heavily Reliant on 83% Debt, Raisin...

What You Should Know:  – The recent acquisition of Walgreens Boots Alliance by p...

Hospitals Face Mounting Supply Chain Crisis, Survey Rev...

What You Should Know:  A new survey from symplr®, a provider of enterprise healt...

Xerox + Connecticut Children’s Introduce AI to Pediatri...

What You Should Know:  – Connecticut Children’s and Xerox are collaborating to r...

Mobile Health Appoints Kenneth Faltischek as CEO

What You Should Know:  – Mobile Health, a national leader in occupational health...

symplr Appoints Chief Commercial Officer & Chief Produc...

What You Should Know:  – symplr®, a provider of enterprise healthcare operations...

Dr. Oz says he would defend Medicare drug price negotia...

Mehmet Oz has committed to defending Medicare drug price negotiations in court i...

Federal Circuit ruling keeps Amgen's Eylea biosimilar o...

The US Court of Appeals for the Federal Circuit on Friday ruled against Regenero...

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.